Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when ITGR files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsInteger Holdings transitions CRM & Neuromodulation President to special projects role
Filed June 26, 2026 · Period ending June 24, 2026 · ~1 min read
Key Changes
-
medium
Jim Stephens moves from President of Cardiac Rhythm Management & Neuromodulation to Executive Vice President, Special Projects, effective June 29, 2026, with role ending March 31, 2027.
Item 5.02 — Departure of Directors or Certain Officers; Compensation verify on EDGAR → -
medium
The nine-month assignment is time-limited and can be terminated early by either party, suggesting a transitional arrangement rather than a permanent executive position.
Item 5.02 — Departure of Directors or Certain Officers; Compensation verify on EDGAR → -
low
If a Change of Control occurs before March 31, 2027, and Stephens remains employed through that date, his separation will be treated as termination without Cause for severance purposes.
Item 5.02 — Departure of Directors or Certain Officers; Compensation verify on EDGAR →
Summary
Integer Holdings is transitioning Jim Stephens from his role as President of Cardiac Rhythm Management & Neuromodulation to Executive Vice President, Special Projects, effective June 29, 2026. The new role is explicitly time-limited, ending March 31, 2027, with either party able to terminate earlier. This nine-month assignment represents a shift from leading a major operating division to a special projects capacity.
For retail investors, this signals a leadership change in one of Integer's core business segments.The Change of Control provisions protect Stephens' severance rights if the company is acquired during this period. Watch for announcements regarding permanent leadership for the Cardiac Rhythm Management & Neuromodulation division.
Section-by-Section Diff
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On June 24, 2026, the Compensation and Organization Committee (the “Committee”) of the Board of Directors (the “Board”) of Integer Holdings Corporation (the “Company”) approved certain changes to the compensation for Jim Stephens, the Company’s current President, Cardiac Rhythm Management & Neuromodulation, in connection with his transition to the role of Executive Vice President, Special Projects, effective June 29, 2026.
Jim Stephens is moving from President of Cardiac Rhythm Management & Neuromodulation to Executive Vice President, Special Projects, effective June 29, 2026. The Compensation Committee approved compensation changes for this new role. This represents a shift from an operating division leadership role to a special projects position.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
Mr. Stephens will not be eligible for a short-term or long-term incentive award in 2027.
Stephens will not receive short-term or long-term incentive awards in 2027, consistent with his transitional role ending in the first quarter of that year. All other employment terms remain unchanged.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 29, 2026 · How we verify